PPARG and Miyoshi myopathy: On the other hand, the treatment of cell line MOLP8 with PPARγ antagonist BADGE (Bisphenol A diglycidyl ether) in association with VPA/PIO diminish the cytotoxicity of the co-treatment VPA/PIO on MM cell line (Table 5) and the H3 acetylation state is also decreased.